Charney Laurence N
Charney Laurence N, DIR, reported an open-market or private sale at TG THERAPEUTICS, INC. involving 5000.000000 shares for an estimated $274800.00. Reported holdings after the transaction were 168640.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Sep 10, 2026
- Filing date
- Sep 14, 2026
How reported position traded is calculated
Shares sold ÷ (holdings after + shares sold). Estimated position before: 173,640 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
TGTX price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- Sell Code S
- Identifier
- 0001437749-26-030343 Common Stock
- Transaction date
- Sep 10, 2026 Filed Sep 14, 2026, 09:00 PM · 4d delay
- Shares
- 5,000 sh $54.96 per share
- Estimated value
- -$274k Computed from shares × price
- Holdings after
- 168,640 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
+6 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
No officer title
- F1
These shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Charney's income tax obligations.
- F2
Price is the volume weighted average price of all transactions made by the Reporting Person on the transaction date for prices ranging from $54.92 to $54.99. The Reporting Person undertakes to provide…
- F3
Includes shares of restricted Common Stock, which vest over various time periods.
0 other transactions
0 recent txs